These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21312259)

  • 21. Feasibility and safety of triple dose platelet collection by apheresis.
    Moog R
    J Clin Apher; 2009; 24(6):238-40. PubMed ID: 19908304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Amicus Separator in the collection of apheresis platelets.
    Yockey C; Murphy S; Eggers L; Garratty G; Dingle A; Helms C; Moroff G
    Transfusion; 1998 Sep; 38(9):848-54. PubMed ID: 9738625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
    Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
    Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated platelet collection using the latest apheresis devices in an Indian setting.
    Agarwal P; Verma A
    Transfus Apher Sci; 2009 Oct; 41(2):135-8. PubMed ID: 19709930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of plateletpheresis on the Fenwal CS-3000 on donor platelet counts.
    Kalish RI; Chambers LA; Linden JV
    J Clin Apher; 1987; 3(4):230-4. PubMed ID: 3680195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analysis of Various Aspects of Plateletpheresis on the Fenwal Amicus and Fresenius COM.TEC Cell Separator Instruments.
    Philip J; Biswas AK; Chatterjee T; Mallhi RS
    Lab Med; 2014; 45(4):315-23. PubMed ID: 25316663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plateletpheresis efficiency and mathematical correction of software-derived platelet yield prediction: A linear regression and ROC modeling approach.
    Jaime-Pérez JC; Jiménez-Castillo RA; Vázquez-Hernández KE; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
    J Clin Apher; 2017 Oct; 32(5):329-334. PubMed ID: 27862253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of concurrent red blood cell and platelet collection by apheresis in a university haemapheresis unit.
    Moog R
    Transfus Med; 2004 Apr; 14(2):145-50. PubMed ID: 15113378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
    Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
    J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
    Enein AA; Hussein EA; El Shafie S; Hallouda M
    J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
    Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
    J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minor diurnal and activity-induced variations in daytime peripheral blood platelet counts do not have any major impact on platelet yield by platelet apheresis.
    Akkök CA; Hervig T; Bjørsvik S; Underdal MO; Skoug CF; Ersvaer E; Bruserud Ø
    Transfus Apher Sci; 2010 Aug; 43(1):33-6. PubMed ID: 20558109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plateletpheresis experience with the Haemonetics Blood Processor 30, the IBM Blood Processor 2997, and the Fenwal CS-3000 Blood Processor.
    Kurtz SR; McMican A; Carciero R; Melaragno A; Abdu W; Katchis R; Valeri CR
    Vox Sang; 1981; 41(4):212-8. PubMed ID: 7336674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet apheresis with Vivacell BT798 DEA, haemonetics V-50 and PCS-Plus: preparation efficiency and product quality using identical donors.
    Richter E; Pawlow I; Krause KP; Matthes G
    Infusionsther Transfusionsmed; 1992 Oct; 19(5):249-50. PubMed ID: 1288770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
    Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
    Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leuko-reduction using an integral Sepacell filter early (4 h, 24 h) or late (48 h, 120 h) after plateletpheresis does not affect platelet function.
    Müller TH; Schmidt S; Döscher A; Weiss H; Schunter F
    Beitr Infusionsther Transfusionsmed; 1997; 34():95-9. PubMed ID: 9356661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.